$59.99
0.72[1.21%]
At close: Apr 17
$59.99
0[0.00%]
PreMarket: 4:05PM EDT
Keros Therapeutics
(NASDAQ:KROS)Keros Therapeutics Stock (NASDAQ:KROS), Earnings Estimates, EPS, and Revenue
Keros Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 2
EPS Estimate
$-1.340
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$151K
Analyze the earnings history of Keros Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/02/2024 | PM | KROS | Q1 | -$1.26 | -$1.34 | — | — | $0.00 | — | — | — | Get Alert |
| 02/28/2024 | PM | KROS | Q4 | -$1.09 | -$1.37 | -$1.34 | 2.19% | $0.00 | — | $143.00K | — | Get Alert |
| 11/06/2023 | AM | KROS | Q3 | -$0.92 | -$1.35 | -$1.33 | 1.48% | $0.00 | — | $8.00K | — | Get Alert |
| 08/07/2023 | AM | KROS | Q2 | -$1.13 | -$1.34 | -$1.27 | 5.22% | $0.00 | $220.00K | $0.00 | -100.00% | Get Alert |
| 05/04/2023 | PM | KROS | Q1 | -$1.01 | -$1.12 | -$1.26 | -12.50% | $0.00 | $220.00K | $0.00 | -100.00% | Get Alert |
| 03/03/2023 | PM | KROS | Q4 | -$0.30 | -$1.10 | -$1.09 | 0.91% | $20.00M | $860.00K | $0.00 | -100.00% | Get Alert |
| 11/03/2022 | AM | KROS | Q3 | -$0.87 | -$1.23 | -$0.92 | 25.20% | $0.00 | — | $0.00 | — | Get Alert |
| 08/04/2022 | PM | KROS | Q2 | -$0.67 | -$1.06 | -$1.13 | -6.60% | $100.00K | — | $0.00 | — | Get Alert |
| 05/05/2022 | PM | KROS | Q1 | -$0.68 | -$0.86 | -$1.01 | -17.44% | $0.00 | — | $0.00 | — | Get Alert |
| 03/09/2022 | PM | KROS | Q4 | -$0.49 | -$0.94 | -$0.30 | 68.09% | $0.00 | — | $20.00M | — | Get Alert |
| 11/04/2021 | PM | KROS | Q3 | -$0.60 | — | -$0.87 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/05/2021 | PM | KROS | Q2 | -$0.62 | -$0.65 | -$0.67 | -3.08% | $0.00 | — | $100.00K | — | Get Alert |
| 05/06/2021 | PM | KROS | Q1 | -$5.11 | -$0.58 | -$0.68 | -17.24% | $0.00 | — | $0.00 | — | Get Alert |
| 03/25/2021 | AM | KROS | Q4 | -$1.32 | — | -$0.49 | — | — | — | $0.00 | — | Get Alert |
| 11/10/2020 | PM | KROS | Q3 | -$1.71 | — | -$0.60 | — | — | — | $0.00 | — | Get Alert |
| 08/13/2020 | AM | KROS | Q2 | -$1.44 | — | -$0.62 | — | — | — | $0.00 | — | Get Alert |
| 05/22/2020 | AM | KROS | Q1 | — | — | -$5.11 | — | — | — | $0.00 | — | Get Alert |
FAQ
When is Keros Therapeutics (NASDAQ:KROS) reporting earnings?
Keros Therapeutics (KROS) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
What were the latest earnings per share (EPS) for Keros Therapeutics (NASDAQ:KROS)?
The Actual EPS was $-1.34, which beat the estimate of $-1.37.
What were Keros Therapeutics’s (NASDAQ:KROS) revenues?
The Actual Revenue was $143K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.